Journal issue - WANFANG MED ONLINE

Contact US | Chinese

You Position: Home > Journal issue

Acta Pharmaceutica Sinica

Issue 2, 2020

Items 1-5 of 24

«Preious | of 5 | Next»

1

Establishment of an in vitro screening model for uranium decorporation chelators based on the competitive ELISA method

Acta Pharmaceutica Sinica, Volume 55, Issue 2,2020, Pages 265-271, doi:10.16438/j.0513-4870.2019-0687

2

The mechanism of anti-hepatocellular carcinoma cell line HepG2 by Chinese medicine Astragalus protein

Acta Pharmaceutica Sinica, Volume 55, Issue 2,2020, Pages 241-246, doi:10.16438/j.0513-4870.2019-0684

3

Progress in clinical pharmacology of oligonucleotides

Acta Pharmaceutica Sinica, Volume 55, Issue 2,2020, Pages 218-225, doi:10.16438/j.0513-4870.2019-0834

4

由同情用药发展为Ⅲ期临床研究的瑞德西韦

Acta Pharmaceutica Sinica, Volume 55, Issue 2,2020, Pages 345-348, doi:10.16438/j.0513-4870.2020-0103

5

Strategies for the development of drugs targeting novel coronavirus 2019-nCoV

Acta Pharmaceutica Sinica, Volume 55, Issue 2,2020, Pages 181-188, doi:10.16438/j.0513-4870.2020-0106

Items 1-5 of 24

«Preious | of 5 | Next»

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn